Trials / Completed
CompletedNCT03200769
Study of the Efficacy of the Treatment of Sleep Apnea Syndrome by CPAP in Pharmacoresistant Epilepsy
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 103 (actual)
- Sponsor
- University Hospital, Lille · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Study of the Efficacy of the Treatment of Sleep Apnea Syndrome by CPAP in Pharmacoresistant Epilepsy. The primary goal is to evaluate the efficacity after 3 months of obstructive sleep apnea syndrome treatment by CPAP on the epilepsy seizures frequency.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | CPAP active | CPAP PR1 Philips Respironics with a pression between 4 and 14 mm Hg |
| DEVICE | CPAP placebo | CPAP PR1 Philips Respironics with a constant pression of 4 mm Hg. |
Timeline
- Start date
- 2014-07-21
- Primary completion
- 2021-07-01
- Completion
- 2021-07-01
- First posted
- 2017-06-27
- Last updated
- 2022-09-30
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT03200769. Inclusion in this directory is not an endorsement.